leadf
logo-loader
viewAbbott Laboratories

Abbott Laboratories' Covid-19 antibody test approved by UK authorities

US authorities warned on Thursday that the kit may deliver inaccurate results, allegation refuted by the company

Abbott Laboratories - Abbott Laboratories' Covid-19 antibody test approved by UK authorities

Abbott Laboratories Inc. (NYSE:ABT) Covid-19 antibody test was approved by UK authorities.

ID NOW identifies whether an individual has been exposed to the coronavirus and developed an immune response to it, which experts say helps understanding immunity and potentially lift restrictions.

READ: UK in talks to buy Roche’s Covid-19 antibody tests following US, EU lead

The product has been authorised in the US for emergency use and is not approved otherwise.

However, the US Food and Drug Administration warned on Thursday that Abbott’s kit may deliver inaccurate results, after receiving 15 reports of false negatives.

The agency, which is investigating the matter, said it can be used but negative results need to be double-checked with other tests.

Abbott pointed out that some studies have employed ID NOW “in ways that it was not designed to be used” and said it is clarifying the product information to provide better guidance.

“Negative results should be presumed negative, but if inconsistent with clinical signs and symptoms or necessary for patient management, should be tested with an alternative molecular assay,” the company said.

On Thursday, UK authorities said they were in talks with Swiss pharma giant Roche to buy its Covid-19 antibody tests after Public Health England said it is effective.

Shares in Abbott dropped 3% to US$89.18 in premarket trading.

Quick facts: Abbott Laboratories

Price: 107.9 USD

NYSE:ABT
Market: NYSE
Market Cap: $191.24 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Ascendant Resources drill program continues looking to expand south zone at...

Ascendant Resources (TSE: AND) President and CEO Chris Buncic joined Steve Darling from Proactive with news the company's drill program continues as the look at the South Zone of the Lagoa Salgada Project in Portugal. Buncic telling Proactive they are expecting to have results from this...

15 hours, 9 minutes ago

2 min read